Status:
COMPLETED
Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy
Lead Sponsor:
Tom Baker Cancer Centre
Collaborating Sponsors:
MSI Foundation
University of Calgary
Conditions:
Pancreas Cancer
Periampullary Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pancreaticoduodenectomy (PD or Whipple procedure) involves the removal of the head of the pancreas and is the primary modality for treatment of peri-ampullary cancers (arising from the common bile duc...
Eligibility Criteria
Inclusion
- Suspected pancreatic or periampullary neoplasm that appears to be resectable based on preoperative imaging (CT scan and/or MRI) and are deemed medically fit to undergo PD.
Exclusion
- Patients less than 18 years of age will be excluded.
- As well, patients with distant metastasis, local unresectability, and/or gastric involvement will be excluded.
- Other exclusion criteria include:
- female subjects who are pregnant or nursing
- current use of an investigational drug
- currently receiving chemotherapy or radiotherapy.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT00841607
Start Date
August 1 2006
End Date
May 1 2013
Last Update
October 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N4N2